Effects of angiotensin inhibitors on renal injury and angiotensin receptor expression in early hypertensive nephrosclerosis

Hypertension Research - Clinical and Experimental

Volumn 22, Issue 4, 1999, Pages 303-312

  Nakaya, Hideaki ^a   Sasamura, Hiroyuki ^a   Kitamura, Yudai ^a   Amemiya, Tetsuro ^a   Konishi, Konosuke ^a   Hayashi, Matsuhiko ^a   Saruta, Takao ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Angiotensin; Nephrosclerosis; Receptor

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN ANTAGONIST; ANGIOTENSIN RECEPTOR; CANDESARTAN HEXETIL; DELAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFICACY; GLOMERULUS; HEART HYPERTROPHY; HYPERTENSION; KIDNEY FAILURE; MALE; MESSENGER RNA SYNTHESIS; NEPHROSCLEROSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PROTEINURIA; RAT; RENAL ARTERY; ULTRASTRUCTURE;

EID: 0032725656     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.22.303     Document Type: Article

References (31)

1. Maschio G, Alberti D, Janin G, et al: Effect of the angiotensin-converting-enzyme benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996; 334: 939-945.
2. Giatras I, Lau J, Levey AS: Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Ann Intern Med 1997; 127: 337-345.
3. Lafayette RA, Mayer G, Park SK, Meyer TW: Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 1992; 90: 766-771.
4. Kim S, Ohta K, Hamaguchi A, et al: Contribution of renal angiotensin II type 1 receptor to gene expressions in hypertension-induced renal injury. Kidney Int 1994; 46: 1346-1358.
5. Okada H, Suzuki H, Kanno Y, Ikenaga H, Saruta T: Renal responses to angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor in partially nephrectomized spontaneously hypertensive rats. J Cardiovasc Pharmacol 1995; 26: 564-569.
6. Dzau VJ, Sasamura H, Hein L: Heterogeneity of angiotensin synthetic pathways and receptor subtypes: physiological and pharmacologic implications. J Hypertens 1993; 11 (Suppl 3): S13-S18.
7. Arima S, Endo Y, Yaoita H, et al: Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole. J Clin Invest 1998; 100: 2816-2823.
8. Siragy HM, Carey RM: The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 1997; 100: 264-269.
9. Lo M, Liu KL, Lantelme P, Sassard J: Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats. J Clin Invest 1995; 95: 1394-1397.
10. Sasamura H, Dzau VJ, Pratt RE: Desensitization of angiotensin receptor function. Kidney Int 1994; 46: 1499-1501.
11. Sasamura H, Suzuki H, Kato R, Saruta T: Effects of angiotensin II, ACTH, and KCl on the adrenal renin-angiotensin system in the rat. Acta Endocrinol 1990; 122: 369-373.
12. Kanno Y, Suzuki H, Okada H, Saruta T: Renal protective effects of amlodipine on partially nephrectomized spontaneously hypertensive rats fed a high-salt diet. J Cardiovasc Pharmacol 1994; 23: 480-484.
13. Fujiwara K, Kanno Y, Hayashi K, Takenaka T, Saruta T: Renal protective effects of efonidipine in partially nephrectomized spontaneously hypertensive rats. Clin Exp Hypertens 1998; 20: 295-312.
14. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
15. Kitamura Y, Sasamura H, Nakaya H, Maruyama T, Hayashi M, Saruta T: Effects of ACTH on adrenal angiotensin II receptor subtype expression in vivo. Mol Cell Endocrinol 1998; 146: 187-195.
16. Iwai N, Inagami T: Identification of two subtypes in the rat type 1 angiotensin II receptor. FEBS Lett 1992; 298: 257-260.
17. Shanmugam S, Lenkei ZG, Gasc JR, Corvol PL, Llorens-Cortes CM: Ontogeny of angiotensin II type 2 (AT2) receptor mRNA in the rat. Kidney Int 1995; 47: 1095-1100.
18. Tso JY, Sun XH, Kao TH, Reece KS, Wu R: Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 1985; 13: 2485-2502.
19. Ichikawa I: Angiotensin II receptors and renal hemodynamics and function. Blood Press Suppl 1996; 2: 19-21.
20. Kim S, Iwao H: Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1 receptor antagonist on gene expression and the cellular phenotype. J Hypertens Suppl 1997; 15: S3-S7.
21. Tarif N, Bakris GL: Angiotensin II receptor blockade and progression of nondiabetic-mediated renal disease. Kidney Int Suppl 1997; 63: S67-S70.
22. Inada Y, Wada T, Ojima M, et al: Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens 1997; 19: 1079-1099.
23. Zhuo J, Dean R, MacGregor D, Alcorn D, Mendelsohn FA: Presence of angiotensin II AT2 receptor binding sites in the adventitia of human kidney vasculature. Clin Exp Pharmacol Physiol Suppl 1996; 3: S147-S154.
24. Matsubara H, Sugaya T, Murasawa S, et al: Tissue-specific expression of human angiotensin II AT1 and AT2 receptors and cellular localization of subtype mRNAs in adult human renal cortex in situ hybridization. Nephron 1998; 80: 25-34.
25. Ozono R, Wang Z, Moore AF, Inagami T, Siragy HM, Carey RM: Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 1997; 30: 1238-1246.
26. Wolf G, Ziyadeh FN, Thaiss F, et al: Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells: role of the angiotensin type 2 receptor. J Clin Invest 1997; 100: 1047-1058.
27. Sharma M, Sharma R, Greene AS, McCarthy ET, Savin VJ: Documentation of angiotensin II receptors in glomerular epithelial cells. Am J Physiol 1998; 274: F623-F627.
28. Lassegue B, Alexander RW, Nickenig G, Clark M, Murphy TJ, Griendling KK: Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms-evidence for homologous and heterologous regulation. Mol Pharmacol 1995; 48: 601-609.
29. Iwai N, Inagami T: Regulation of the expression of the rat angiotensin II receptor mRNA. Biochem Biophys Res Commun 1992; 182: 1094-1099.
30. Shibata K, Makino I, Shibaguchi H, Niwa M, Katsuragi T, Furukawa T: Up-regulation of angiotensin type 2 receptor mRNA by angiotensin II in rat cortical cells. Biochem Biophys Res Commun 1997; 239: 633-637.
31. Kijima K, Matsubara H, Murasawa S, et al: Regulation of angiotensin II type 2 receptor gene by the protein kinase C-calcium pathway. Hypertension 1996; 27 (part 2): 529-534.